Table 2.
Univariate survival analysis (Kaplan-Meier) and log rank test
| Characteristic | No. of cases | No. of events | Two-year survival rate (± SE) in % | p-value | |
|---|---|---|---|---|---|
| XAF1 expression | 291 | 103 | |||
| Low | 152 | 66 | 71.8 ± 3.7 | 0.018 | |
| High | 139 | 37 | 84.7 ± 3.1 | ||
| PT-Status | < 0.001 | ||||
| pT1/2 | 145 | 28 | 92.3 ± 2.2 | ||
| pT3/4 | 146 | 75 | 63.7 ± 4.0 | ||
| Fuhrman grade | < 0.001 | ||||
| G 1/2 | 129 | 25 | 88.1 ± 2.9 | ||
| G 3/4 | 162 | 78 | 69.4 ± 3.7 | ||
| Metastases | < 0.001 | ||||
| M0/x | 241 | 68 | 84.8 ± 2.3 | ||
| M1 | 50 | 35 | 43.7 ± 7.3 | ||
Survival times of patients with clear-cell RCC according to clinico-pathological characteristics and nuclear XAF1 protein expression levels.